Best Biological Products Stocks by Growth Stability

27 Biological Products stocks ranked by Steady Score — the proprietary growth stability rating based on 10 years of financial data.

Data as of 2026-08-01

Top stock: BIO-TECHNE Corp (TECH) with Steady Score 68.27.

Stocks: 27
Avg Steady Score: 42.9
High stability (score ≥ 75): 0
Avg Revenue CAGR: +26.3%

Of the 27 Biological Products stocks, 0 (0%) have high growth stability (Steady Score ≥ 75). The industry average Steady Score is 42.9, with average annualized revenue growth of +26.3% and earnings growth of -3.6%.

Rank	Name	Ticker	Steady Score	Revenue CAGR	Earnings CAGR	Dividend CAGR
1	BIO-TECHNE Corp	TECH	68.27	+11.2%	+5.7%	+0.8%
2	AMGEN INC	AMGN	65.95	+5.0%	+2.0%	+5.8%
3	GILEAD SCIENCES, INC.	GILD	57.29	+1.3%	-9.5%	+5.4%
4	Vericel Corp	VCEL	56.96	+19.2%	n/a	n/a
5	NEUROCRINE BIOSCIENCES INC	NBIX	56.81	+57.7%	n/a	n/a
6	EXELIXIS, INC.	EXEL	55.45	+26.8%	n/a	n/a
7	REPLIGEN CORP	RGEN	51.67	+25.8%	n/a	n/a
8	CHAMPIONS ONCOLOGY, INC.	CSBR	51.49	+15.8%	n/a	n/a
9	ADMA BIOLOGICS, INC.	ADMA	48.36	+57.1%	n/a	n/a
10	HALOZYME THERAPEUTICS, INC.	HALO	48.27	+28.3%	n/a	n/a
11	CURIS INC	CRIS	46.86	+1.6%	n/a	n/a
12	ImmunityBio, Inc.	IBRX	42.5	+104.4%	n/a	n/a
13	Protalix BioTherapeutics, Inc.	PLX	41.96	+16.0%	n/a	n/a
14	NOVAVAX INC	NVAX	40.74	+74.5%	n/a	n/a
15	Cardiff Oncology, Inc.	CRDF	38.83	+5.4%	n/a	n/a
16	Editas Medicine, Inc.	EDIT	37.68	+17.2%	n/a	n/a
17	BIOGEN INC.	BIIB	36.98	-3.4%	-12.6%	n/a
18	AGENUS INC	AGEN	36.05	+18.4%	n/a	n/a
19	REGENXBIO Inc.	RGNX	35.83	+33.2%	n/a	n/a
20	BIOCRYST PHARMACEUTICALS INC	BCRX	35.18	+55.6%	n/a	n/a
21	Lineage Cell Therapeutics, Inc.	LCTX	34.6	+15.1%	n/a	n/a
22	FATE THERAPEUTICS INC	FATE	32.7	+21.6%	n/a	n/a
23	SUTRO BIOPHARMA, INC.	STRO	32.2	+9.4%	n/a	n/a
24	Voyager Therapeutics, Inc.	VYGR	31.17	+25.1%	n/a	n/a
25	CRISPR Therapeutics AG	CRSP	26.86	+6.5%	n/a	n/a
26	AIM ImmunoTech Inc.	AIM	26.57	-6.0%	n/a	n/a
27	Moderna, Inc.	MRNA	22.06	+67.7%	n/a	n/a

How is Steady Score calculated?